臨床眼科76巻11号

2022年10月発行

増刊号 最新臨床研究から探る眼科臨床のギモンQ＆A 2　白内障・視覚矯正

老視矯正を考えるうえで，どのように多焦点レンズを選べばよいでしょうか？

著者： 荒井宏幸¹

所属機関： ¹みなとみらいアイクリニック

ページ範囲：P.83 - P.89

患者の希望と多焦点レンズの特性をマッチングさせることがポイントです．

参考文献

1）Schallhorn JM et al：Multifocal and accommodating intraocular lenses for the treatment of presbyopia：a report by the American Academy of Ophthalmology. Ophthalmology 128：1469-1482, 2021

2）Marchini G et al：Functional assessment of two different accommodative intraocular lenses compared with a monofocal intraocular lens. Ophthalmology 114：2038-2043, 2007

3）Dhital A et al：Comparison of near vision, intraocular lens movement, and depth of focus with accommodating and monofocal intraocular lenses. J Cataract Refract Surg 39：1872-1878, 2013

4）United States Food and Drug Administration. Premarket Approval Application P980040/S065；Summary of Safety and Effectiveness, 2016（https://www.accessdata.fda.gov/cdrh_docs/pdf/P980040S065B.pdf）（閲覧日：2022年8月29日）

5）Gil MA et al：Comparison of far and near contrast sensitivity in patients symmetrically implanted with multifocal and monofocal IOLs. Eur J Ophthalmol 24：44-52, 2014

6）Peng C et al：Optical performance after bilateral implantation of apodized aspheric diffractive multifocal intraocular lenses with ＋3.00-D addition power. Acta Ophthalmol 90：e586-e593, 2012

7）United States Food and Drug Administration. Premarket Approval Application P040020/S087；Summary of Safety and Effectiveness, 2019（https://www.accessdata.fda.gov/cdrh_docs/pdf4/P040020S087B.pdf）（閲覧日：2022年8月29日）

8）United States Food and Drug Administration. Premarket approval application P980040/S049；Summary of Safety and Effectiveness, 2014（https://www.accessdata.fda.gov/cdrh_docs/pdf/P980040S049B.pdf）（閲覧日：2022年8月29日）

9）Pedrotti E et al：Comparative analysis of visual outcomes with 4 intraocular lenses：Monofocal, multifocal, and extended range of vision. J Cataract Refract Surg 44：156-167, 2018

10）Ang R et al：Prospective evaluation of visual outcomes with three presbyopia-correcting intraocular lenses following cataract surgery. Clin Ophthalmol 7：1811-1823, 2013

11）Pepose JS et al：A prospective randomized clinical evaluation of 3 presbyopia-correcting intraocular lenses after cataract extraction. Am J Ophthalmol 158：436-446, 2014

12）Alfonso JF et al：Intermediate visual function with different multifocal intraocular lens models. J Cataract Refract Surg 36：733-739, 2010

13）Cillino G et al：Working-age cataract patients：visual results, reading performance, and quality of life with three diffractive multifocal intraocular lenses. Ophthalmology 121：34-44, 2014

14）Maxwell WA et al：Functional outcomes after bilateral implantation of apodized diffractive aspheric acrylic intraocular lenses with a ＋3.0 or ＋4.0 diopter addition power Randomized multicenter clinical study. J Cataract Refract Surg 35：2054-2061, 2009

15）Cochener B et al：A comparative evaluation of a new generation of diffractive trifocal and extended depth of focus intraocular lenses. J Refract Surg 34：507-514, 2018

16）McAlinden C et al：The development of an instrument to measure quality of vision：the Quality of Vision（QoV）questionnaire. Invest Ophthalmol Vis Sci 51：5537-5545, 2010

17）Nuijts RM et al：Bilateral implantation of ＋2.5 D multifocal intraocular lens and contralateral implantation of ＋2.5 D and ＋3.0 D multifocal intraocular lenses：Clinical outcomes. J Cataract Refract Surg 42：194-202, 2016

18）Cochener B；Concerto Study Group：Clinical outcomes of a new extended range of vision intraocular lens：International Multicenter Concerto Study. J Cataract Refract Surg 42：1268-1275, 2016

19）Sandoval HP et al：Extended depth-of-focus toric intraocular lens targeted for binocular emmetropia or slight myopia in the nondominant eye：Visual and refractive clinical outcomes. J Cataract Refract Surg 45：1398-1403, 2019

20）Pelli DG et al：Measuring contrast sensitivity. Vision Res 90：10-14, 2013

21）Jonker SMR et al：Comparison of a trifocal intraocular lens with a ＋3.0 D bifocal IOL：results of a prospective randomized clinical trial. J Cataract Refract Surg 41：1631-1640, 2015

22）Maurino V et al：Quality of vision after bilateral multifocal intraocular lens implantation：a randomized trial—AT LISA 809M versus AcrySof ReSTOR SN6AD1. Ophthalmology 122：700-710, 2015

23）United States Food and Drug Administration. Premarket Approval Application P040020/S087；Summary of Safety and Effectiveness, 2019（https://www.accessdata.fda.gov/cdrh_docs/pdf4/P040020S087B.pdf）（閲覧日：2022年8月29日）